Clinical Trial Update: LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing LVN-IUS to oral megestrol acetate for atypical endometrial hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia

Drugs mentioned

• LVN-IUS
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Zagazig University | Conditions: Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: COMPLETED